Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
2015
Breast cancer
2019 Standout
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Antibody-drug conjugates—an emerging class of cancer treatment
2016
Cancer treatment and survivorship statistics, 2022
2022 Standout
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators
2011
Novel radiolabeled antibody conjugates
2007
Recent developments in PET detector technology
2008
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
Thyroid cancer
2016 Standout
Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma
2005
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients
2016
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
2007
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
2015
Cancer Statistics, 2006
2006 Standout
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
2007
Medullary Thyroid Carcinoma
2007
Use of new imaging techniques to predict tumour response to therapy
2010
A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly
2008
Recent updates on CAR T clinical trials for multiple myeloma
2019
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
The minimum crystal size needed for a complete diffraction data set
2010
18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
2016
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Extracellular matrix structure
2015 Standout
Multimodal Imaging Analysis of Tumor Progression and Bone Resorption in a Murine Cancer Model
2006
Radioimmunotherapy of human tumours
2015
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine
2015
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future
2011
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Native structure of photosystem II at 1.95 Å resolution viewed by femtosecond X-ray pulses
2014 StandoutNature
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Imaging and cancer: A review
2008
Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients
2014
Tensor Regression with Applications in Neuroimaging Data Analysis
2013 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies
2005
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
2004
ImageJ for Microscopy
2007 Standout
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
2002
Cell–matrix interactions: focus on proteoglycan–proteinase interplay and pharmacological targeting in cancer
2014
Ce3+-Doped garnet phosphors: composition modification, luminescence properties and applications
2016 Standout
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents
2015
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Cancer treatment and survivorship statistics, 2019
2019 Standout
Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group
2006
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Improved Tumor Selectivity of Radiolabeled Peptides by Receptor and Antigen Dual Targeting in the Neurotensin Receptor Model
2002
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Primary Systemic Therapy of Breast Cancer
2006
Works of Ludovic Ferrer being referenced
Voxeldose: A Computer Program for 3-D Dose Calculation in Therapeutic Nuclear Medicine
2003
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Dosimetric comparison of Monte Carlo codes (EGS4, MCNP, MCNPX) considering external and internal exposures of the Zubal phantom to electron and photon sources
2005
Community-Acquired Pneumonia Among the Elderly: Differences Between Patients Living at Home and in Nursing Homes
2004
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
2015
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
2008
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients
2011
Radioimmunoconjugates for the Treatment of Cancer
2014
Effect of Patient Morphology on Dosimetric Calculations for Internal Irradiation as Assessed by Comparisons of Monte Carlo Versus Conventional Methodologies
2009
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
2012
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
2003
Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission Tomography
2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
2006
Simulation of a high performance λ-camera concept for PET based on liquid xenon and gaseous photomultiplier
2005
Early response monitoring by FDG-PET to neoadjuvant chemotherapy in locally advanced breast cancer patients
2005
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.
1999
La neumonía adquirida en la comunidad de los ancianos: diferencias entre los que viven en residencias y en domicilios particulares
2004